Log in
Enquire now
Aggrenox

Aggrenox

dipyridamole, acetylsalicylic acid

OverviewStructured DataIssuesContributors

Contents

boehringer-ingelheim.com/products/aggrenox
Is a
Product
Product

Product attributes

Industry
Medicine
Medicine
Product Parent Company
Boehringer Ingelheim
Boehringer Ingelheim

The combination drug acetylsalicylic acid/dipyridamole (trade names Aggrenox, Asasantin) is a drug combination of:

Acetylsalicylic acid (Aspirin) - An extremely common NSAID that has anticoagulant effects

Dipyridamole, a drug that inhibits platlet activation when given chronically and causes vasodilation when given at high doses over short time.

The combination acts as an extended release formulation and is primarily used for platelet inhibition in patients suffering, or at risk from, acute coronary events and stroke. Its use has been shown to be better than the use of either dipyridamole or aspirin alone.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like Aggrenox

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.